skip to content
Mental illness medication debate Preview this item
ClosePreview this item
Checking...

Mental illness medication debate

Author: Jane Tanner
Publisher: Washington, D.C. : CQ Press, 2004.
Series: CQ researcher, v. 14, no. 5.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
Armed with new findings on the links between brain chemistry and mental illness, drug companies produced a new generation of drugs for schizophrenia, major depression and other severe psychiatric conditions. Most experts say up to 70 percent of the nation's 17.5 million adult sufferers could recover with access to the new drugs and strong social supports. Yet fewer than half receive any treatment, and the situation  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Jane Tanner
OCLC Number: 62260407
Notes: Title from caption (viewed Nov. 11, 2005).
"February 6, 2004."
Details: Mode of access: World Wide Web.
Series Title: CQ researcher, v. 14, no. 5.
Other Titles: Should more patients have access to new drugs?
Responsibility: by Jane Tanner.

Abstract:

Armed with new findings on the links between brain chemistry and mental illness, drug companies produced a new generation of drugs for schizophrenia, major depression and other severe psychiatric conditions. Most experts say up to 70 percent of the nation's 17.5 million adult sufferers could recover with access to the new drugs and strong social supports. Yet fewer than half receive any treatment, and the situation is eroding as cash-strapped states try to limit public subsidies for the higher-priced new drugs. Some say the new drugs often aren't worth the added costs, but others contend they are cheaper than the alternatives with older drugs -- distressing risks and side-effects and more mentally ill people locked up in prison or homeless.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/62260407> # Mental illness medication debate
    a schema:MediaObject, schema:Book, schema:CreativeWork ;
   library:oclcnum "62260407" ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/1864693073#Place/washington_d_c> ; # Washington, D.C.
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
   schema:about <http://id.loc.gov/authorities/subjects/sh2010101467> ; # Mentally ill--Care--United States
   schema:about <http://experiment.worldcat.org/entity/work/data/1864693073#Topic/mentally_ill_drug_use_united_states> ; # Mentally ill--Drug use--United States
   schema:about <http://id.worldcat.org/fast/1204155> ; # United States.
   schema:about <http://id.worldcat.org/fast/1081826> ; # Psychotropic drugs
   schema:about <http://id.worldcat.org/fast/1016705> ; # Mentally ill--Care
   schema:about <http://id.worldcat.org/fast/1016547> ; # Mental illness
   schema:about <http://id.worldcat.org/fast/1016722> ; # Mentally ill--Drug use
   schema:about <http://dewey.info/class/362.2/e22/> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/1864693073#Topic/psychotropic_drugs_united_states> ; # Psychotropic drugs--United States
   schema:about <http://id.loc.gov/authorities/subjects/sh2010101485> ; # Mental illness--United States
   schema:alternateName "Should more patients have access to new drugs?" ;
   schema:bookFormat schema:EBook ;
   schema:creator <http://viaf.org/viaf/26146854> ; # Jane Tanner
   schema:datePublished "2004" ;
   schema:description "Armed with new findings on the links between brain chemistry and mental illness, drug companies produced a new generation of drugs for schizophrenia, major depression and other severe psychiatric conditions. Most experts say up to 70 percent of the nation's 17.5 million adult sufferers could recover with access to the new drugs and strong social supports. Yet fewer than half receive any treatment, and the situation is eroding as cash-strapped states try to limit public subsidies for the higher-priced new drugs. Some say the new drugs often aren't worth the added costs, but others contend they are cheaper than the alternatives with older drugs -- distressing risks and side-effects and more mentally ill people locked up in prison or homeless."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/1864693073> ;
   schema:genre "Electronic books"@en ;
   schema:inLanguage "en" ;
   schema:isPartOf <http://experiment.worldcat.org/entity/work/data/1864693073#Series/cq_researcher> ; # CQ researcher ;
   schema:name "Mental illness medication debate"@en ;
   schema:productID "62260407" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/62260407#PublicationEvent/washington_d_c_cq_press_2004> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/1864693073#Agent/cq_press> ; # CQ Press
   schema:url <http://library.cqpress.com/cqresearcher/cqresrre2004020600> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/62260407> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/1864693073#Place/washington_d_c> # Washington, D.C.
    a schema:Place ;
   schema:name "Washington, D.C." ;
    .

<http://experiment.worldcat.org/entity/work/data/1864693073#Series/cq_researcher> # CQ researcher ;
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/62260407> ; # Mental illness medication debate
   schema:name "CQ researcher ;" ;
    .

<http://id.loc.gov/authorities/subjects/sh2010101467> # Mentally ill--Care--United States
    a schema:Intangible ;
   schema:name "Mentally ill--Care--United States"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2010101485> # Mental illness--United States
    a schema:Intangible ;
   schema:name "Mental illness--United States"@en ;
    .

<http://id.worldcat.org/fast/1016547> # Mental illness
    a schema:Intangible ;
   schema:name "Mental illness"@en ;
    .

<http://id.worldcat.org/fast/1016705> # Mentally ill--Care
    a schema:Intangible ;
   schema:name "Mentally ill--Care"@en ;
    .

<http://id.worldcat.org/fast/1016722> # Mentally ill--Drug use
    a schema:Intangible ;
   schema:name "Mentally ill--Drug use"@en ;
    .

<http://id.worldcat.org/fast/1081826> # Psychotropic drugs
    a schema:Intangible ;
   schema:name "Psychotropic drugs"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States.
    a schema:Place ;
   schema:name "United States." ;
    .

<http://library.cqpress.com/cqresearcher/cqresrre2004020600>
   rdfs:comment "Access may be restricted to subscribers." ;
    .

<http://viaf.org/viaf/26146854> # Jane Tanner
    a schema:Person ;
   schema:familyName "Tanner" ;
   schema:givenName "Jane" ;
   schema:name "Jane Tanner" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.